Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-06

Clinical Trial Update: Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy [NA]

View source ↗

Summary

Clinical trial update on vorinostat for stage IV breast cancer in patients receiving hormone therapy; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vorinostat (vorinostat)

Snippet

Sponsor: University of Washington | Conditions: Male Breast Cancer, Recurrent Breast Cancer | NA | Status: COMPLETED | Results posted: 2014-11-06